Roivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million

Reuters2026/09/02 01:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Roivant Sciences President and Immunovant CEO Eric Venker cut his stake to 1,599,154 common shares on Aug. 28, 2026.
Disposed of 200,000 shares at prices of USD 35.63 and USD 36.44.
Exercised stock options for 200,000 shares at USD 3.85.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-035375), on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Roivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million

You may also like

Crypto prices